JPRN-UMIN000050517
Not yet recruiting
未知
Study on the Efficacy of Remission Induction Therapy Based on Comprehensive Analysis of Colorectal Mucosa Gene Expression in Ulcerative Colitis - Comprehensive colorectal mucosal gene expression in ulcerative colitis and prediction of treatment response.
Conditionsulcerative colitis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- ulcerative colitis
- Sponsor
- Kyoto Prefectural University of Medicine
- Enrollment
- 100
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(i) Women who are pregnant or may become pregnant (ii) Patients after total colorectal resection (iii) Patients whom the attending physician deems inappropriate
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Phase II study of remission induction therapy with bendamustine and rituximab combination (BR) therapy followed by consolidation therapy with 90Y-labeled iburitumomab tiuxetan for relapsed follicular lymphoma.(BRiZ2012 protocol)follicular lymphomaJPRN-UMIN000008793Society of Lymphoma Treatment in Japan (SoLTJ)28
Active, not recruiting
Phase 1
Evaluation of the impact of remission induction chemotherapy prior to allogeneic stem cell transplantation in relapsed and poor-response patients with AMEUCTR2014-003124-44-DEDKMS gemeinnützige GmbH308
Completed
Phase 2
A phase II study of the remission induction and maintenance therapy by rituximab for rituximab naive low grade B cell lymphoma.low grade B cell lymphomaJPRN-UMIN000001191Clinical Hematology Study Group of National Hospital Organization(CHSG-NHO)42
Not yet recruiting
Not Applicable
A Study of Treatment-free remission Evaluation in Real-world chronic myeloid leukemia-Prospective observational studyKCT0007901Gachon University Gil Medical Center200
Withdrawn
Phase 2
Investigating the effect of therapeutic acute intermittent hypoxia on upper limb and respiratory function in people more than one year post spinal cord injury: The AERO-SCI trialACTRN12622000648729Austin Health40